NEW

UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

oneSOURCE Creates Free Resource Page with Up-to-Date COVID-19 Vaccine Information

Today, oneSOURCE, an RLDatix company and leading healthcare management solution, announced a new COVID-19 vaccine resource page to assist healthcare professionals during the initial administration phases of the vaccine.

STERIS to Acquire Cantel Medical

STERIS plc and Cantel Medical Corp. announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary. Cantel is a global provider of infection prevention products and services primarily to endoscopy and dental Customers.

NEC Releases ‘WISE VISION Endoscopy’ in Europe and Japan

NEC Corporation has announced the development of “WISE VISION Endoscopy,” an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan and is expected to soon be available in Europe.

Palmero Healthcare DisCide Ultra Surface Disinfectant

Many disinfectants need up to 10 minutes to take effect – crucial time when it comes to keeping your practice surfaces clean and safe for patients, clinicians and staff. DisCide Ultra Disinfectant is a one-step intermediate hospital grade disinfectant, cleaner and decontaminant. With its expanded list of kill claims, DisCide is proven to kill 27 deadly pathogens (including TB) in 1 minute or less, accelerating your practice’s operatory turnover. DisCide Ultra is EPA registered and ready to use without any mixing or measuring. Available in towelettes, spray and bulk gallon refills, DisCide Ultra spray and large-sized towelettes are available in identical formulations to ensure efficacy when liquid and towelettes are used together.

For more information, call 800-344-6424

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X